
Pegheal 6mg Injection
Marketer
Biochem Pharmaceutical Industries
Salt Composition
Pegfilgrastim (6mg)
Overview Pegheal 6mg Injection
Filgrastim 6mg injection combats post-chemotherapy infections. This growth factor boosts white blood cell production in bone marrow, enhancing infection resistance. Administration is solely by a healthcare professional via injection, following your physician's prescribed duration. Treatment length depends on individual response. Regular blood cell and bone density monitoring is typical. Common side effects include bone, joint, and muscle aches, headache, and nausea; injection site pain or redness is also frequent. Report persistent lumps, swelling, or bruising. While it doesn't guarantee complete infection prevention, report fever, chills, respiratory distress, sore throat, or facial/neck swelling. Inform your doctor about all other medications, as interactions are possible. Avoid use during pregnancy or breastfeeding; effective contraception is crucial for both partners. Refrain from driving or activities demanding focus if dizziness occurs.
Uses of Pegheal 6mg Injection
Infectious disease prophylaxis following chemotherapy
Major Benefits of Pegheal 6mg Injection:
The medication will be administered by your physician or their qualified staff; please do not attempt self-medication.
Common Side effects of Pegheal 6mg Injection:
- Bone pain
- Joint pain
- Headache
- Nausea
- Low blood platelets
- Muscle pain
- Back pain
- Pain in extremities
- Injection site pain
How to use Pegheal 6mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Pegheal 6mg Injection works:
Filgrastim 6mg injection promotes white blood cell production within the bone marrow, bolstering the body's infection-fighting defenses.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Pegheal 6mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Pegheal 6mg Injection during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administering Pegheal 6mg Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible harm to the infant.
DrivingSAFE
Driving ability is typically unaffected by Pegheal 6mg Injection.
KidneySAFE IF PRESCRIBED
Pegheal 6mg Injection poses no safety concerns for patients with renal impairment; dose modification is unnecessary.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Pegheal 6mg Injection's use in individuals with hepatic impairment. Seek medical advice from your physician.
What if you forget to take Pegheal 6mg Injection :
Omit a Pegheal 6mg Injection dose? Seek your physician's advice.
Facts to Know About Pegheal 6mg Injection
| Label | Value |
|---|---|
| Type of Compound | Growth factor for granulocytes. |
| Potential for Dependence | None. |
| Type of Treatment | Cancer-fighting drugs |
| Mechanism of Action | A growth factor stimulating granulocyte production. |
